Cell Culture Market and Top Companies Global Growth, Manufacturing Investments and Technology Shifts

November 4, 2026 |

1 min read

The global cell culture market was valued at USD 22.95 billion in 2025 and is projected to reach USD 25.55 billion in 2026 and approximately USD 60.38 billion by 2035, registering a CAGR of 11.35% from 2026 to 2035. The expansion reflects the growing use of cell-based methods in biologics manufacturing, drug discovery, vaccine production, diagnostics and regenerative medicine.

Download a sample of the Cell Culture Market report – https://www.towardshealthcare.com/download-sample/5385

Market indicator	Value
Market size, 2024	USD 20.61 billion
Market size, 2025	USD 22.95 billion
Estimated market size, 2026	USD 25.55 billion
Forecast market size, 2035	USD 60.38 billion
CAGR, 20262035	11.35%
Leading region, 2023	North America
Fastest-growing region	Asia Pacific

Market Definition

Cell culture is the process of growing and maintaining living cells in a controlled laboratory environment. Cells may come from humans, animals, plants or microorganisms and are maintained using suitable nutrients, temperature, pH, humidity and gas conditions.

The market covers the products and equipment required for this work, including culture media, sera, reagents, vessels, incubators, centrifuges, cryostorage equipment and automated culture systems. These products support research laboratories as well as commercial manufacturing facilities producing vaccines, monoclonal antibodies and other biological medicines.

Market Key Takeaways

➝ Consumables held the leading product position in 2024, supported by repeated purchases of media, sera, reagents and culture plastics.

➝ Biopharmaceutical production was the largest application in the report's 2023 assessment.

➝ Diagnostics is identified as a fast-growing application, supported by infectious disease testing and cell-based analytical methods.

➝ North America accounted for 36% of the global market in 2023.

➝ Asia Pacific is expected to record the fastest regional growth.

➝ Stem cell culture media, 3D culture models, automation and organoid technologies are creating new product opportunities.

Market Trends

Cell culture is moving beyond conventional two-dimensional laboratory methods. Researchers and manufacturers are adopting 3D culture systems, organoids, scaffold-based platforms and organ-on-a-chip technologies to create models that more closely represent human tissue behaviour. These approaches can support drug screening, toxicity testing and disease research.

Automation is another important development. Automated feeding, passaging, imaging and cell monitoring can reduce manual work and improve consistency. AI-assisted analysis may also help researchers identify changes in cell growth and culture conditions earlier. For manufacturers, these tools can support process monitoring and more reproducible production.

A further shift is the growing use of serum-free and chemically defined media. These formulations can help reduce variability associated with biological raw materials and support more controlled manufacturing processes. Demand for specialized media is also increasing as cell types and production applications become more diverse.

Market Drivers, Restraints and Opportunities

Drivers: Rising demand for monoclonal antibodies, vaccines, recombinant proteins and other biologics is increasing the need for reliable cell culture systems. Pharmaceutical and biotechnology companies also use cell cultures throughout drug discovery, development and process optimization. Growth in cell and gene therapy research adds demand for specialized media, reagents and cell expansion technologies.

Restraints: Contamination and cell misidentification remain important concerns. Bacterial, fungal, viral or chemical contamination can compromise experiments, delay manufacturing and increase operating costs. Maintaining consistent cell lines, validated procedures and quality-controlled raw materials requires skilled staff and investment.

Opportunities: Regenerative medicine, stem cell research, tissue engineering and advanced disease models create opportunities for specialized culture products. Suppliers that can offer validated media, reliable cell lines, scalable systems and integrated monitoring solutions are well positioned to serve both research and manufacturing customers.

Market Segmentations

By Product

Segment	Market position	Growth trend	Business opportunity
Consumables	Leading product segment	Recurring demand from research and production	Media, sera, reagents and sterile plastics offer repeat-purchase opportunities
Instruments	Supporting product segment	Demand for advanced and automated equipment	Incubators, culture systems, centrifuges and cryostorage equipment support laboratory and manufacturing upgrades

Consumables benefit from their regular use across research and production workflows. Media, sera and reagents are essential for maintaining cell growth, while culture vessels and plastics support sterile handling. Stem cell culture media is identified as a notable growth area within consumables. Instruments serve a different purchasing cycle, with demand linked to laboratory expansion, automation and manufacturing capacity.

By Application

Segment	Market position	Growth trend	Business opportunity
Biopharmaceutical production	Dominant application	Supported by biologics and vaccine manufacturing	High-volume demand for scalable culture systems and specialized media
Diagnostics	Fast-growing application	Increasing use in infectious disease and genetic testing	Cell-based testing and analytical solutions
Drug development	Established application	More complex screening and preclinical models	Advanced cell lines, assay platforms and automated analysis
Tissue culture and engineering	Emerging growth area	Increasing research in tissue models	Specialized media, scaffolds and 3D systems
Cell and gene therapy	Emerging strategic application	Expanding therapy development and manufacturing needs	Cell expansion, processing and quality-monitoring solutions
Toxicity testing and other uses	Supporting applications	Demand for improved experimental models	Reproducible cell-based testing platforms

Biopharmaceutical production remains central to market demand because cell culture is used to manufacture monoclonal antibodies, vaccines and therapeutic proteins. Diagnostics is expected to grow quickly as cell-based methods support pathogen identification and other laboratory applications. Meanwhile, tissue engineering and cell and gene therapy offer opportunities for suppliers able to meet more specialized quality and process requirements.

Market Regional and Country-Level Analysis

Region / country	Market position	Key development or trend	Business opportunity
North America	Largest region; 36% share in 2023	Established biotechnology ecosystem and strong R&D infrastructure	Biologics manufacturing, advanced instruments and specialized media
United States	Major regional contributor	Investment in domestic biomanufacturing and cell therapy capacity	Manufacturing supply, automation and process development
Canada	Established research base	Biotechnology research and biomanufacturing investment	Research-grade products and cell therapy supply chains
Asia Pacific	Fastest-growing region	Expanding biologics production and government-backed life-science development	Local manufacturing, media supply and laboratory infrastructure
China	Major growth market	Expansion of biologics manufacturing and domestic biotechnology	Scalable culture products and production technologies
Japan and South Korea	Advanced research markets	Progress in 3D culture and regenerative medicine	Specialized cell models and advanced research systems
India	Growing biotechnology and vaccine base	Expanding pharmaceutical research and biologics production	Cost-effective consumables, media and manufacturing support
Europe	Established market	Strong pharmaceutical research and biologics development	Quality-focused media, process solutions and advanced culture systems
Latin America	Developing market	Growth in biomedical research and vaccine development	Laboratory modernization and research consumables
Middle East and Africa	Emerging market	Investment in healthcare research and advanced treatment capabilities	Laboratory infrastructure and specialist cell culture products

North America benefits from established biotechnology companies, research institutions and biopharmaceutical manufacturing infrastructure. The report identifies a 36% regional share in 2023. Asia Pacific is expected to grow fastest, supported by expanding manufacturing capabilities and research activity in China, Japan, South Korea and India. Europe remains important for pharmaceutical research and biologics development, while Latin America and the Middle East and Africa offer developing opportunities as laboratory capabilities expand.

Company and Competitive Intelligence

The competitive landscape includes global life-science suppliers, specialist cell technology companies and manufacturers of research products and bioprocess equipment.

Company	Market role and competitive focus
Thermo Fisher Scientific	Cell culture media, reagents, laboratory products and bioprocess solutions
Danaher Corporation	Bioprocessing technologies and life-science platforms through its businesses
Merck KGaA	Cell culture media, raw materials and bioprocessing products
Sartorius AG	Bioprocess equipment, cell culture products and manufacturing solutions
Lonza Group	Cell culture media, cell line development and biologics manufacturing services
Corning Incorporated	Cell culture vessels, surfaces and laboratory consumables
STEMCELL Technologies	Specialized cell culture products and stem cell research solutions
Bio-Techne Corporation	Reagents, growth factors and research products
Terumo Blood and Cell Technologies	Cell processing and cell expansion technologies
FUJIFILM Corporation	Cell culture products, biomanufacturing and advanced therapy manufacturing

Recent Industry Developments

Investment in manufacturing infrastructure is strengthening the supply side of the market. In May 2026, FUJIFILM Cellular Dynamics opened a new 175,000-square-foot iPSC development and manufacturing facility in Madison, Wisconsin. The facility is part of a USD 200 million investment and is expected to quadruple the company's manufacturing capacity for iPSC-based research products and services.

Sartorius announced a new competence centre in Freiburg, Germany, in May 2026. The approximately 18,000-square-metre site is focused on developing and producing quality-critical materials, including cytokines and growth factors used in cell and gene therapy. Production was planned to begin toward the end of 2026.

In July 2026, FUJIFILM Biotechnologies announced that its Holly Springs, North Carolina, manufacturing facility had been selected for the FDA PreCheck Pilot Program. The site operates mammalian cell culture bioreactors and is expanding its drug-substance capacity. This development highlights the importance of manufacturing readiness and regulatory engagement for large-scale biologics production.

Johnson & Johnson also announced a more than USD 1 billion investment in a next-generation cell therapy manufacturing facility in Pennsylvania in February 2026. Although focused on cell therapy rather than the broader research cell culture market, the investment reflects the increasing need for specialized manufacturing infrastructure and skilled production capacity.

On November 2, 2026, the FDA issued final guidance on potency assurance for cellular and gene therapy products. The guidance emphasizes quality controls across development and manufacturing, including consideration of raw-material variability and testing throughout production. This reinforces the importance of reliable cell processes, analytical methods and quality systems across advanced therapy manufacturing.

Emerging Opportunities for Cell Culture Companies

The next phase of market competition will depend on more than product availability. Buyers increasingly need suppliers that can demonstrate consistency, traceability, scalability and technical support. Opportunities include serum-free media, specialized stem cell formulations, automated monitoring, 3D culture platforms, organoids and manufacturing-grade cell expansion systems.

Suppliers can also differentiate themselves through regional production, validated raw materials, customization and partnerships with biotechnology companies, research institutes and CDMOs. Understanding where competitors are expanding, which technologies they are prioritizing and what customers require can support better commercial decisions.

How Towards Healthcare Supports Cell Culture Market Decisions

Towards Healthcare Research & Consulting provides market intelligence and customized research to help companies assess opportunities, compare competitors and plan commercial strategies.

Solution	What clients receive	How it helps in the cell culture market
Master Dataset	Company, product, facility, capacity, supplier, technology and partnership data	Identifies competitors, suppliers, manufacturing footprints and market opportunities
Towards Healthcare Strategic Positioning Quadrant™	Company benchmarking, portfolio comparison and strategic positioning	Compares suppliers by product range, capabilities, technology and market presence
Interactive Dashboard	Market, company, segment, regional and investment indicators	Tracks changes and supports faster decisions than static reports
Quality & Manufacturing Intelligence	Facility locations, production capacity, manufacturing processes and quality-related intelligence	Supports supplier assessment, sourcing and manufacturing planning
Customized Research	Market entry, buyer intelligence, pricing, competitor analysis and opportunity mapping	Helps companies evaluate countries, customer groups and commercial strategies

Continuous Market Intelligence Updates

Monthly updates can track company announcements, product launches, partnerships and investment activity. Quarterly reviews can assess market shifts, competitor positioning, pricing and regional developments. Six-monthly assessments can evaluate capacity changes, technology adoption and supplier movements. Annual updates can refresh market sizing, forecasts, segment performance and long-term strategy.

These updates help manufacturers, suppliers, investors and biotechnology companies respond to changes in demand and competition.

Request Cell Culture Market Intelligence

Fill out the form for relevant samples, case studies, and examples.

➝ Purchase the Cell Culture Market report - https://www.towardshealthcare.com/checkout/5210

➝ Schedule a meeting with Towards Healthcare - https://www.towardshealthcare.com/contact-us

Related Reports